This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
TRPV1 antibody (A00128-4) performs well in ELISA, Flow Cytometry, IF, ICC, WB and shows reactivity with Human, Rat.
| Reactive Species | Host | Application |
|---|---|---|
| Human, Rat | Rabbit | ELISA, Flow Cytometry, IF, ICC, WB |
TRPV1 antibody was positively detected by WB in:
human 293T whole cell, human HepG2 whole cell, rat liver tissue, rat PC-12 whole cell
Suggested blocking solution with 5% non-fat milk or BSA; (*)Recommended protein loading: 20-40 ug per lane
TRPV1 antibody was positively detected by ICC/IF in:
T-47D cell
TRPV1 antibody was positively detected by FC in:
U87 cell
* It is recommended to optimize the amount of this reagent in each experimental system to achieve the best results.
Note: For flow cytometry (FCM), suitable for fixed cells only. Not suitable for FACS or surface flow cytometry using live cells.
95.0 kDa
Submit a review and receive $370 in product credits, a $185 Amazon gift card, or our carefully curated gift bundles.

| SKU | A00128-4 |
|---|---|
| Application | Western blot |
| Sample | Rat MADB106 breast cancer cells |
| Sample Processing Description | Normally cultured MADB106 cells, MADB106 cells treated with an agonist, MADB106 cells treated with an inhibitor |
| Other Reagents | RIPA lysis buffer (Cat. No. AR0102, Bosterbio, Wuhan) Protease inhibitor, Running buffer, Transfer buffer, Blocking buffer |
| Primary Antibody | TRPV1 Antibody Picoband® |
| Primary Incubation | 1:2000, overnight at 4 ℃ |
| Secondary Antibody | 1:10,000, HRP-conjugated Goat Anti-Rabbit IgG |
| Secondary Incubation | 1h at 37℃ |
| Detection | Substrate: ECL substrate, Imaging system:ChemiDoc MP |
| Results Summary | The role of TRPV1 in breast cancer research is highly complex, varying with cell type, tumor subtype, and tumor microenvironment, and in some cases even showing contradictory effects. The current consensus is that TRPV1 is not only a potential therapeutic target for breast cancer but also an important prognostic and regulatory factor. Experimental results show that TRPV1 protein expression markedly increases in cells treated with an agonist, while it decreases in cells treated with an inhibitor. |
Xinshuo Wang, Xi’an Jiaotong University
Verified customer
Submitted 2026-02-12
We promise Anti-TRPV1 Antibody Picoband® performs excellently in relevant applications for ELISA, Flow Cytometry, IF, ICC, WB. If it doesn't perform as promised, we will refund the product. Learn more
We promise all of our products perform as described in datasheets.
This product is for Research Use Only. Not for use in diagnostic procedures.